Posted on 11/29/17
Ortho Clinical Diagnostics Recognized with Global Business Excellence Award
Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced that it has received a Global Business Excellence Award for Ortho's VITROS® NEPHROCHECK™ . . .
Posted on 3/26/18
Q BioMed Adds Boston University’s Dr. Helen Tager-Flusberg to Advisory Committee
Q BioMed Inc., a New York-City-based biotechnology acceleration company, announced that Dr. Helen Tager-Flusberg from Boston University has joined its advisory committee for QBM-001, which is . . .
Posted on 11/21/17
Pfizer Inc. 2017 Q3 - Results - Earnings Call Slides
The following slide deck was published by Pfizer Inc. in conjunction with their 2017 Q3 earnings call. 111READ FULL ARTICLE HERE
Posted on 11/21/17
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on November 15, 2017 it approved non-statutory stock options to purchase an aggregate of 61,500 shares of its . . .
Posted on 11/20/17
Can This Tiny Biotech Stock Pay Off Big for Celgene?
Celgene Corp (NASDAQ:CELG) loves cozying up to emerging biotech stocks working on next-generation medicine, and one of those collaborations is with Jounce Therapeutics(NASDAQ:JNCE). Celgene inked a . . .
Posted on 11/20/17
Acorda Announces Royalty Monetization Transactions for $53 Million
ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) announced a $40 million royalty monetization with HealthCare Royalty Partners (HCR) and a $13 million royalty monetization with H. . . .
Posted on 11/19/17
Johnson & Johnson: Enticing Valuation
The right time to buy a dividend growth stock is widely debated. No investor wants to feel like they are over paying for a stock, yet . . .
Posted on 11/15/17
Motif Bio secures up to US$20 million debt financing
NEW YORK, Nov. 15, 2017 (GLOBE NEWSWIRE) -- Motif Bio plc (AIM:MTFB) (NASDAQ:MTFB), a clinical stage biopharmaceutical company specialising in developing novel antibiotics, announced today that . . .
Posted on 11/14/17
Your Daily Pharma Scoop: Regeneron's Appeal, Good News For Amgen, Bristol-Myers' Sprycel
This abridged “Daily Scoop” is published by Avisol Capital Partners, which runs the physician-managed Total Pharma Tracker healthcare investment research service on Seeking Alpha Marketplace.Analysis of . . .
Posted on 11/13/17
Synergy Pharmaceuticals Prices Offering of Common Stock and Warrants
NEW YORK--(BUSINESS WIRE)--Synergy Pharmaceuticals Inc. (Nasdaq:SGYP), a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal therapies, today announced the pricing of its underwritten . . .
Posted on 11/13/17
NYC Oral Surgeon Dr. Mark Stein and Prosthodontist Dr. Anthony Classi Offer Same Day Dental Restorations in New York City
New York, NY, Nov. 13, 2017 (GLOBE NEWSWIRE) -- Dr. Mark Stein, a renowned oral surgeon in NYC, and Dr. Anthony Classi, an expert in the . . .
Posted on 11/12/17
Stemline Therapeutics Reports Third Quarter 2017 Financial Results
NEW YORK, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage biopharmaceutical company developing novel therapeutics for difficult to treat cancers, announced today . . .
Posted on 11/8/17
Better Buy: Novavax, Inc. vs. Pfizer Inc.
Pfizer (NYSE:PFE) ranks as one of the giants of the pharmaceutical market, with a blockbuster vaccine franchise. Novavax (NASDAQ:NVAX) is only a fraction of Pfizer's size . . .
Posted on 11/8/17
Here's Why Regeneron Pharmaceuticals Inc. Slipped 10% in October
What happenedShares of Regeneron Pharmaceuticals Inc. (NASDAQ:REGN) took a hit last month as investors adjusted their outlook for a recently launched eczema drug with megablockbuster potential. . . .
Posted on 11/8/17
GSK Consumer Healthcare and CVS Health Partner
In support of Lung Cancer Awareness Month, GSK Consumer Healthcare, CVS Health and the American Lung Association's LUNG FORCE are joining together to help people quit . . .
Posted on 11/8/17
New Jersey Doctor Opens MDVIP-Affiliated Primary Care Practice
MDVIP, the national leader in affordable personalized healthcare, announced that Claudine M. De Dan, M.D., has opened an MDVIP-affiliated practice in Mullica Hill, N.J., to provide . . .
Posted on 11/7/17
Here's Why Stemline Therapeutics Inc. Jumped 23% Higher in October
What happenedShares of Stemline Therapeutics Inc. (NASDAQ:STML), a clinical-stage biotech developing therapies that target cancer stem cells, shot up 23% in October according to data from . . .
Posted on 11/7/17
Pernix Therapeutics Announces Sale of Non-Core Product
MORRISTOWN, N.J., Nov. 06, 2017 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced the sale of a non-core product, Cedax® . . .
Posted on 11/7/17
4G Clinical Named to Top 20 Most Promising Pharma and Life Science Technology Solution Providers 2017
4G Clinical announced its recognition today as one of the top 20 pharma and life science technology providers of 2017 for its RTSM solution, Prancer.The award . . .
Posted on 11/7/17
The Medicines Company and Alnylam Pharmaceuticals Announce Initiation of Phase III Clinical Trials of Inclisiran
PARSIPPANY, N.J. & CAMBRIDGE, Mass.--(BUSINESS WIRE)--The Medicines Company (NASDAQ: MDCO) and Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) today announced the initiation of the Phase III clinical program . . .
Posted on 11/6/17
Johnson & Johnson Pipeline Impresses
Johnson & Johnson (JNJ) is a $376 billion market cap company trading at $140 per share focused on innovative health care products for people around the . . .
Posted on 11/6/17
The Cost Benefit of Health Care Transparency
As our nation seeks solutions to help improve the healthcare system, there is at least one goal we can all agree on: the importance of making . . .
Posted on 11/6/17
5 Tips To Help Americans Prepare For Open Enrollment And Save On Healthcare Costs
More than 70 percent of Americans say they are prepared for open enrollment, yet most people struggle to understand basic health insurance terms, according to a . . .
Posted on 11/6/17
3 Reasons It's Smart to Buy Celgene's Stock Now
Celgene Corp. (NASDAQ:CELG) shares nose-dived in October following a trial failure and third-quarter financials that failed to impress. However, there are good reasons investors ought to . . .
Posted on 11/6/17
Why Celgene Crashed 30% in October -- and What Now?
What happenedFew industry watchers expected much out of GED-0301, yet its failure in a phase 3 study, plus anemic sales growth for one of its most . . .

